Cytotoxic T lymphocytes (CIL) specific for human immunodeficiency virus (HIV) proteins have been analyzed in lymphoid organs from seropositive patients. Indeed, an active HIV replication coexists with a major CD8' lymphocytic infiltration in these organs. We have shown in a previous report that HIVseropositive patients lungs were infiltrated by HIV specific CD8' lymphocytes. In the present report, we show that HIVspecific CIL responses can also be detected in lymph nodes and spleens, and were mainly directed against the ENV, GAG, and NEF HIV-1 proteins. The primary NEF-specific CTL responses were further characterized by epitope mapping. Determination of epitope-specific CIL frequencies were performed by limiting dilution analysis. Our results indicated that, in addition to the central region of NEF (AA66-148), a new immunodominant region is recognized by CIL. This region corresponds to the carboxyl-terminal domain of NEF (amino acids 182-206). AA182-206 is recognized in association with at least two common human histocompatibility leukocyte antigen (HLA) molecules (HLA-A1 and B8), with clonal frequencies of one CIL per 10' to 10-6 splenic lymphocytes. Our data indicate that lymphoid organs may represent a major reservoir for in vivo activated HIV-specific CTL. Furthermore, the carboxylterminal domain of NEF was found to be conserved among several HIV strains. Therefore, our finding is of interest for further HIV vaccines development. (J. Clin. Invest. 1992. 
1. Abbreviations used in this paper: AA, amino acid; CTL, cytotoxic T lymphocyte; E/T, effector/target ratio; ITP, idiopathic thrombopenic purpura; LDA, limiting dilution analysis; PGL, persistent generalized lymphadenopathy; RVV, recombinant vaccinia virus; VAC, vaccinia virus.
be effective in the control of human immunodeficiency virus (HIV) infection in humans. This underlines the interest of studying cell-mediated immunity to HIV and identifying specific epitopes that stimulate CTL. Numerous reports have demonstrated the presence of HIV-protein-specific CTL in the peripheral blood from infected patients (4) (5) (6) (7) . In previous studies, we have evidenced tissular HIV-specific CTL in lungs of HIVseropositive patients with lymphocytic alveolitis (8) (9) (10) . In contrast, the function and the fine specificity for HIV of these CD8+ cells infiltrating lymphoid organs have not yet been investigated, despite frequent reports of the coexistence of HIV particles and a massive CD8+ cell infiltration within the germinal centers (1 1-13) . This germinal center can thus be considered as a critical site for interaction between HIV and immunocompetent cells. Moreover, the in situ production of various cytokines, such as interleukin 6 (IL-6) or interferon (IFN), strongly suggests that CD8+ cells present in the germinal centers might be involved in anti-HIV CTL responses (14) .
The structural and regulatory proteins of HIV-1 are recognized by CTL, and their epitope mapping is currently under investigation (5, (15) (16) (17) (18) (19) . Previous studies with murine CTL specific for adenovirus or cytomegalovirus early genes have shown efficient protection against viral infection (3, 20) . Therefore, immune responses directed against early HIV regulatory proteins could represent efficient defenses against viruses. The strong immunogenicity of NEF for both B cells and CTL (21) could play a role in the in vivo control of HIV replication (22, 23) . These data suggest that the determination of new consensus epitopes within this early regulatory protein should be relevant in view of vaccine development.
In the present study, we analyze the cytotoxic T cell responses specific for HIV proteins in lymphoid organs from seropositive patients, with special regard to specificities directed against the NEF early regulatory protein. The detection of CTL specific for HIV in primary assays contrasts with general observations for antiviral T cell responses and could be related to the abnormally high frequencies of in vivo differentiated effector CTL specific for ENV and GAG proteins (24) . These properties allowed us to define new NEF epitopes which are recognized in primary polyclonal CTL responses. Furthermore, the relative frequencies of such epitope-specific primary CTL had been defined in limiting dilution analysis (LDA).
Methods

Recombinant vaccinia viruses (R VV)
RVV expressing HIV viral gene products have been used to characterize virus-specific CTL. The viruses used were the wild-type strain Co- 
Results
GAG-, ENV-, and NEF-specific CTL are present in lymphoid organs. In order to investigate HIV-specific CTL responses in lymphoid organs with special regard to the NEF specificities, we analyzed T cell-mediated cytotoxicity directed against HIV proteins in spleen and lymph node cells harvested from patients with ITP or PGL. HIV-specific cytotoxic T cells were first studied in spleen cells from two HIV-seropositive patients with ITP. We used as target cells HLA-matched allogeneic EBV-transformed B-cell lines infected by RVV expressing a panel of HIV-l proteins. As shown in Table II , we detected primary cytotoxic activities against ENV and NEF in both cases, and an anti-GAG activity in one case. We failed to detect any VIF or TAT protein-specific lysis. The primary cytotoxic responses specific for NEF were restricted by HLA class I molecules in both cases in that they were not detectable when tested against target cells incompatible for HLA class I molecules (Fig. 1) . We could individualize two restricting elements for the NEF antigen: HLA-B8 in patient AB and HLA-A1 in patient BR. Similarly, the ENVspecific lysis observed in -patient AB appeared to be MHC restricted, inasmuch as no lysis could be detected on ENV-expressing target cells that were totally mismatched for HLA class I or class II molecules. In contrast, although we could not esti- S mate the MHC class II restriction of patient BR whose HLA class II haplotype was not available, the primary response for ENV was not restricted by MHC class I molecules (Fig. 1 b) . This finding is in agreement with previously described findings for ENV-specific cytotoxicity in peripheral blood (7) . Cytotoxic responses specific for HIV were also analyzed in lymph node lymphocytes from two patients with PGL. Pathologic examination of lymph node sections revealed a follicular hyperplasia. In both cases, the NEF-specific CTL were detectable only after an in vitro restimulation, as shown in Fig. 2 for patient GO. This is in contrast to a low ENV-specific CTL activity which was detectable in primary response (Fig. 2 a) .
These results were compared with data obtained in lungs from patients with HIV-related lymphocytic alveolitis. We had previously reported the detection ofalveolar HIV-specific CTL in such patients by using as target cells P815 cells doubly transfected with HLA and HIV genes (10) . As shown in Fig. 3 primary NEF-specific cytotoxic activity was detected in 4 of 12 patients, whereas it was detected in 3 of 6 patients for both ENV and GAG. We did not detect any lysis against TAT or VIF proteins (data not shown). These primary cytotoxic responses detected in lungs were restricted by HLA class I antigens for all three HIV proteins studied, including the ENV protein (Fig. 3 c) .
Altogether, these data demonstrate that primary CTL responses specific for NEF are detectable in spleens as well as in lungs from seropositive patients with ITP In order to further investigate these peptide-specific CTL, we quantified the relative frequencies of patient BR splenic cytotoxic effector cells directed against the two regions defined above. Results of LDA indicate high frequencies for effector CTL directed against the carboxyl-terminus peptides (5 X 10-6 cells and 2 X 10-5 cells for P182-198 and P192-206, respectively). CTL specific for the central region ofNEF had frequencies ranging between 1.5 X 10-4 and 2 X 10-6 (Fig. 5 ). In contrast, the LDA failed to detect any effector cells (< 10-') reacting with peptides (P4-18, P46-60) that were not recognized in bulk assays (data not shown) or with the control B cell line alone. (Fig. 6) .
In order to confirm the ability of the HLA-A 1 molecule to present the epitopes defined above, we performed similar LDA in several HLA-A 1 patients. We selected alveolar lymphocytes from two HLA-A1 patients with CD8' lymphocytic alveolitis and studied their effector cell frequencies against the HLA-A 1-matched B-cell line coated with PI peptide. Interestingly, we obtained the same range of frequencies (1.5-3 X 10-) as observed for patient BR splenic lymphocytes (data not shown). The P1 13-128 peptide of the NEF molecule can thus be recognized in the context of the HLA-A1 molecule by splenic and alveolar lymphocytes from three distinct HIV-infected patients. In contrast, when testing splenic lymphocytes from a fourth HLA-A patient AB, no HLA-A -restricted primary cytotoxic effector cells could recognize either the NEF central P1 13-128 or the NEF carboxyl-terminus P182-198, P192-206 peptides (Fig. 7) . Moreover, precursors of CTL specific for those peptides were not detectable in LDA after an in vitro restimulation ofpatient AB splenic lymphocytes with the HLA-A1 B-cell line coated with peptides 113-128, 182-198, or 192-206 (data not shown). Since the NEF-specific splenic CTL from this patient were restricted by the HLA-B8 rather than by the HLA-Al antigen, we tested whether these peptides could be presented by the HLA-B8 molecule. Indeed, we could demonstrate that P182-198, but not P1 13-128 nor P192-206, was recognized in association with the HLA-B8 antigen, with an effector cells frequency of 1 X 10' (Fig. 7) .
These overall data indicate that the HLA-A1 and B8 antigens are able to present efficiently epitopes located in both the central and carboxyl-terminal regions of NEF to CTL specific for the NEF protein.
Discussion
In this study, we investigated cytotoxic T cell responses specific for HIV in lymphoid organs where both an active HIV replication and a massive CD8 infiltration have been observed (11) (12) (13) . We report the first demonstration ofprimary specific cytotoxic T cell responses against HIV proteins detected in spleens from seropositive patients with ITP. These responses are similar to that observed in lungs from patients with HIV-related interstitial pneumonitis by our group (8) (9) (10) (8, 10, 30) . Thus, lymphoid organs may represent a major reservoir for HIV-specific CTL which could participate both in the control of HIV replication level and in the subsequent follicule lysis.
The CTL responses directed against early proteins have been shown to play an active role in the control of viral replication or spread, in several viral infections (3, 20) . Since NEF is an early regulatory protein which is not expressed in infectious particles, the NEF-specific CTL response could play a critical role in host cytotoxic defenses against infected cells at an early step ofthe HIV replication. The detection ofNEF-specific CTL responses observed in lymphoid organs and lungs was similar to that observed against the structural ENV and GAG proteins, confirming the high immunogenicity for this regulatory protein (15) (16) (17) . These data prompted us to further investigate the fine specificity of tissular CTL directed against NEF.
We report here a new antigenic region (AA 182-206) located at the carboxyl-terminal region of the NEF molecule which is recognized by CTL in the context of HLA-A or B8 molecules, together with a set ofpeptides mapping in the previously published region located within AA73-82 and 113-128 (15, 17) . Moreover, we report that two common HLA molecules, HLA-Al and B8, are also able to present the P66-80, P93-106, P113-128, and P132-147 central peptides apart from the previously reported HLA A3, Al 1, B17, B37, B18 molecules (15, 17) .
The observation that several HIV peptides can be simultaneously recognized by CTLs from a single donor seems rather unusual as compared with previous studies performed in other viral models where a single immunodominant epitope is usually recognized in association with a single HLA molecule (31, 32) . However, those latter studies were performed on T cell 58 Hadida et al. (35) , allowed us to observe a striking parallel between these epitopes. Indeed, as shown in Fig. 8 
